May 2020 tender notification

Medicines

Tender Closed

PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2019/20 Invitation to Tender, dated 1 November 2019.

Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by:

  • For new listings, by 4pm on 12 June 2020 or the 5th of the month prior to listing, whichever is earlier
  • For price changes, by 4pm on the 12th of the month prior to the date of subsidy change

PHARMAC cannot list a product (and pharmacies cannot claim) without this information. 

More information about this process and NOPC forms can be found on our website.

Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand(external link)  and that a CTPP code has been obtained from the New Zealand Universal List of Medicines(external link). Pharmacodes and CTPP codes must be provided to PHARMAC by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest). PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.

Download the Tender results

2019/20 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2023

CORRECTION to February 2020 tender notification

PHARMAC incorrectly notified a Sole Subsidised Supply Status award in February 2020 for gemcitabine hydrochloride injection in Section B (community) when this should have been an award for Hospital Supply Status in Part II of Section H (Hospital Medicines List). Correction in strikethrough and bold below:

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

1.   Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical name

Presentation;
Pack size and type

Current
pack price

New
pack price

Sole supply brand (Supplier)

Date of listing

Sole Subsidised Supply date

Brand (Supplier) affected by delisting

Gemcitabine hydrochloride

Inj 10 mg per ml, 100 ml vial;
1 vial pack

$15.89

$15.89

Gemcitabine Ebewe
(Novartis)

1 April 2020

1 July 2020

Eli Lilly (Gemzar)

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

2. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

The decisions were as follows:

Chemical name

Presentation;
Pack size and type

Current
pack price

New
pack price

Hospital supply brand
(Supplier)

DV
Limit

Listing date

Hospital Supply Status date

Gemcitabine

Inj 10 mg per ml, 100 ml vial;
1 vial pack

$15.89

$15.89

Gemcitabine Ebewe
(Novartis)

1%

1 April 2020

1 July 2020

CORRECTION to April 2020 tender notification

PHARMAC incorrectly notified the dates relating to the bisoprolol fumarate tablet tender awards. Corrections are in bold and strikethrough below.

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

3.   Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical name

Presentation;
Pack size and type

Current
pack price

New
pack price

Sole supply brand (Supplier)

Date of listing

Sole Subsidised Supply date

Brand (Supplier) affected by delisting

Bisoprolol fumarate1

Tab 2.5 mg;
90 tablet blister pack

$3.53

$1.84

Bisoprolol Mylan
(Mylan)

1 September 2020
1 November 2020

1 February 2021
1 April 2021

Bosvate
(Douglas)

Bisoprolol fumarate1

Tab 5 mg;
90 tablet bottle pack

$5.15

$2.55

Bisoprolol Mylan
(Mylan)

1 September 2020
1 November 2020

1 February 2021
1 April 2021

Bosvate
(Douglas)

Bisoprolol fumarate1

Tab 10 mg;
90 tablet blister pack

$9.40

$3.62

Bisoprolol Mylan
(Mylan)

1 September 2020
1 November 2020

1 February 2021
1 April 2021

Bosvate
(Douglas)

1 Brand switch fee of $4.50 is payable for this product from 1 February 2021 1 April 2021 to 30 April 2021 30 June 2021  

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

4.   Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical name

Presentation;
Pack size and type

Current
pack price

New
pack price

Sole supply brand (Supplier)

Date of listing

Sole Subsidised Supply date

Brand (Supplier) affected by delisting

Bisoprolol fumarate

Tab 2.5 mg;
90 tablet blister pack

$3.53

$1.84

Bisoprolol Mylan
(Mylan)

1 September 2020
1 November 2020

1 February 2021
1 April 2021

Bosvate
(Douglas)

Bisoprolol fumarate

Tab 5 mg;
90 tablet bottle pack

$5.15

$2.55

Bisoprolol Mylan
(Mylan)

1 September 2020
1 November 2020

1 February 2021
1 April 2021

Bosvate
(Douglas)

Bisoprolol fumarate

Tab 10 mg;
90 tablet blister pack

$9.40

$3.62

Bisoprolol Mylan
(Mylan)

1 September 2020
1 November 2020

1 February 2021
1 April 2021

Bosvate
(Douglas)

2019/20 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2023 - May tender notification

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

1. Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows (changes in bold):

Chemical name

Presentation;
Pack size and type

Current
pack price

New
pack price

Sole supply brand (Supplier)

Date of listing

Sole Subsidised Supply date

Brand (Supplier) affected by delisting

Amoxicillin with clavulanic acid

Tab 500 mg with clavulanic acid 125 mg;
10 tablet blister pack

$1.88
(20 tablet pack)

$0.89

Curam Duo 500/125
(Novartis New Zealand Limited)

1 February 2021

1 July 2021

Augmentin
(GSK)

Anastrozole

Tab 1 mg;
30 tablet blister pack

$5.04

$4.55

Anatrole
(Mylan)

1 November 2020

1 April 2021

Rolin
(Rex Medical)

Calcium carbonate

Tab 1.25 g (500 mg elemental);
250 tablet bottle pack

$7.52

$6.69

Calci-Tab 500
(AFT)

1 December 2020

1 May 2021

Arrow-Calcium
(Teva)

Emulsifying ointment

Oint BP:

500 g tub

$3.59

$3.40

Emulsifying Ointment ADE
(ADE Health Ltd)

1 October 2020

1 March 2021

AFT
(AFT)

Hydroxyurea [Hydroxycarbamide] 2

Cap 500 mg;
100 capsule box pack

$31.76

$23.82

Devatis
(Deva Holdings (NZ) Ltd)

1 September 2020

1 February 2021

Hydrea
(Bristol-Myers Squibb (NZ) Limited)

2 Brand switch fee of $4.50 is payable for this product from 1 February 2021 to 30 April 2021

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

2. Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows (changes in bold):

Chemical name

Presentation;
Pack size and type

Current pack price

New pack price

Hospital supply brand (Supplier)

DV Limit

Listing date

Hospital Supply Status date

Brand (Supplier) affected by delisting

Amoxicillin with clavulanic acid

Tab 500 mg with clavulanic acid 125 mg;
10 tablet blister pack

$1.88
(20 tablet pack)

$0.89

Curam Duo 500/125
(Novartis New Zealand Limited)

1%

1 February 2021

1 July 2021

Augmentin
(GSK)

Anastrozole

Tab 1 mg;
30 tablet blister pack

$5.04

$4.55

Anatrole
(Mylan)

1%

1 November 2020

1 April 2021

Rolin
(Rex Medical)

Calcium carbonate

Tab 1.25 g (500 mg elemental);
250 tablet bottle pack

$7.52

$6.69

Calci-Tab 500
(AFT)

1%

1 December 2020

1 May 2021

Arrow-Calcium
(Teva)

Emulsifying ointment

Oint BP:

500 g tub

$3.59

$3.40

Emulsifying Ointment ADE
(ADE Health)

1%

1 October 2020

1 March 2021

AFT
(AFT)

Hydroxyurea [Hydroxycarbamide]

Cap 500 mg;
100 capsule box pack

$31.76

$23.82

Devatis
(Deva Holdings (NZ) Ltd)

1%

1 September 2020

1 February 2021

Hydrea
(Bristol-Myers Squibb (NZ) Limited)

Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status

PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in:

  • the 2017/18 Invitation to Tender, dated 2 November 2017, and
  • the 2018/19 Invitation to Tender, dated 1 November 2018, and
  • the 2019/20 Invitation to Tender, dated 1 November 2019.

2017/18 Invitation to Tender

Chemical name

Line item

Amoxicillin clavulanate

Grans for oral liq amoxicillin 400 mg with potassium clavulanate 57 mg per 5 ml

Chlorhexidine gluconate

Mouthwash 0.2%

Diclofenac sodium

Eye drops 0.1%

Methotrexate

Inj 7.5 mg prefilled syringe

Methotrexate

Inj 10 mg prefilled syringe

Methotrexate

Inj 15 mg prefilled syringe

Methotrexate

Inj 20 mg prefilled syringe

Methotrexate

Inj 25 mg prefilled syringe

Methotrexate

Inj 30 mg prefilled syringe

Midodrine

Tab 2.5 mg

Midodrine

Tab 5 mg

Mitozantrone

Inj 2 mg per ml, 10 ml

Oxycodone hydrochloride

Oral liq 1 mg per ml

2018/19 Invitation to Tender

Chemical name

Line item

Captopril

Oral liq 5 mg per ml

2019/20 Invitation to Tender

Chemical name

Line item

Amikacin

Inj 15 mg per ml

Amiloride with Hydrochlorothiazide

Tab 5 mg with hydrochlorothiazide 50 mg

Aminophylline

Inj 25 mg per ml, 10 ml

Amoxicillin

Inj 1 g

Amoxicillin

Inj 250 mg

Amoxicillin

Inj 500 mg

Baclofen

Inj 0.05 mg per ml, 1 ml

Betaxolol hydrochloride

Eye drops 0.25%

Betaxolol hydrochloride

Eye drops 0.5%

Bupivacaine hydrochloride

Inj 1.25 mg per ml, 100 ml bag

Bupivacaine hydrochloride

Inj 2.5 mg per ml, 200 ml bag

Bupivacaine hydrochloride

Inj 1.25 mg per ml, 500ml bag

Bupivacaine hydrochloride

Inj 5 mg per ml, 20 ml ampoule

Captopril

Oral liq 5 mg per ml

Cefotaxime

Inj 500 mg

Chlorhexidine gluconate

Soln 4%

Chlorhexidine gluconate

Crm 1% obstetric

Chlorhexidine gluconate

Lotn 1% obstetric

Chloroquine phosphate

Tab 250 mg

Cimetidine

Tab 200 mg

Cimetidine

Tab 400 mg

Clarithromycin

Tab 250 mg

Clarithromycin

Tab 500 mg

Danazol

Cap 100 mg

Danazol

Cap 200 mg

Desmopressin

Nasal drops 100 mcg per ml

Desmopressin

Inj 4 mcg per ml, 1 ml

Desmopressin

Tab 200 mcg

Desmopressin

Inj 15 mcg per ml, 1 ml

Dextrochlorpheniramine Maleate

Oral liq 2 mg per 5 ml

Dinoprostone

Gel 1 mg

Dinoprostone

Gel 2 mg

Doxycycline

Tab 20 mg - 50 mg

Doxycycline

Inj 100 mg per 20 ml

Ethinyloestradiol with Desogestrel

Tab 20 mcg with desogestrel 150 mcg

Ethinyloestradiol with Desogestrel

Tab 30 mcg with desogestrel 150 mcg

Ethinyloestradiol with levonorgestrel

Tab 50 mcg with levonorgestrel 125 mcg

Flucloxacillin sodium

Inj 250 mg

Flucloxacillin sodium

Inj 500 mg

Flucloxacillin Sodium

Inj 2 g

Flucytosine

Cap 500 mg

Glucose [Dextrose]

Tab 3.1 g

Glucose [Dextrose]

Tab 4 g

Glucose [Dextrose]

Tab 1.5 g

Glucose with sucrose and fructose

Gel 19.7% with sucrose 35% and fructose 19.7%, 18 g sachet

Imipramine Hydrochloride

Tab 10 mg

Imipramine Hydrochloride

Tab 25 mg

Imiquimod

Crm 5%

Lidocaine [Lignocaine]

Crm 4%

Lithium carbonate

Cap (immediate-release) 250 mg

Lithium Carbonate

Tab (immediate-release) 250 mg

Lithium Carbonate

Tab long-acting 400 mg

Medroxyprogesterone acetate

Tab 100 mg

Medroxyprogesterone acetate

Tab 2.5 mg

Medroxyprogesterone acetate

Tab 5 mg

Medroxyprogesterone acetate

Tab 10 mg

Melatonin

Tab modified-release 2 mg

Menthol

Crystals

Metoclopramide hydrochloride

Oral liq 5 mg per 5 ml

Mifepristone

Tab 200 mg

Nicardipine hydrochloride

Inj 2.5 mg per ml, 10 ml vial

Nitazoxanide

Oral 100 mg per 5 ml

Nitazoxanide

Tab 500 mg

Noradrenaline

Inj 0.06 mg per ml, 100 ml bag

Noradrenaline

Inj 0.12 mg per ml, 50 ml syringe

Noradrenaline

Inj 1 mg per ml, 100 ml bag

Noradrenaline

Inj 0.16 mg per ml, 50 ml vial

Noradrenaline

Inj 0.16 mg per ml, 100 ml bag

Oestrogens

Conjugated, equine tab 300 mcg

Oestrogens

Conjugated, equine tab 625 mcg

Paracetamol

Tab 500 mg, blister pack

Paracetamol

Tab 500 mg, bottle pack

Paraffin liquid with soft white paraffin

Eye oint with soft white paraffin

Paraffin liquid with wool fat liquid

Eye oint 3% with wool fat liq 3%

Paraldehyde

Inj 5 ml

Perindopril

Tab 2 mg - 2.5 mg

Perindopril

Tab 4 mg – 5 mg

Perindopril

Tab 8 mg – 10 mg

Phenelzine sulphate

Tab 15 mg

Pravastatin

Tab 10 mg

Procaine penicillin

Inj 1.5 mega u

Protionamide

Tab 250 mg

Quinine dihydrochloride

Inj 600 mg

Rasagiline

Tab 1 mg

Rifabutin

Cap 150 mg

Sodium cromoglicate

Nasal spray, 4%

Tramadol hydrochloride

Inj 10 mg per ml, 100 ml bag

Tranylcypromine Sulphate

Tab 10 mg

Triamcinolone acetonide

Inj 10 mg per ml, 1 ml preservative-free

Wool fat with mineral oil

Lotn hydrous 3% with mineral oil, 250 ml

Xylometazoline hydrochloride

Nasal drops 0.1%

Xylometazoline hydrochloride

Aqueous nasal spray 0.05%

Xylometazoline hydrochloride

Aqueous nasal spray 0.1%

Xylometazoline hydrochloride

Nasal drops 0.05%

Zuclopenthixol Acetate

Inj 50 mg per ml, 1 - 2 ml

Zuclopenthixol Decanoate

Inj 200 mg per ml

Zuclopenthixol decanoate

Inj 500 mg per ml

If you have any queries regarding this notification, please contact PHARMAC on 0800 66 00 50.